Kenya
Kenya
Explore linked clinical trials.75 results · Page 1 of 3
Cities
Swipe the table sideways for more columns.
| Cities | City | Country | Linked trials |
|---|---|---|---|
| Ahero | Ahero | Kenya | 1 |
| Ahero | Ahero | Kenya | 2 |
| Akala | Akala | Kenya | 1 |
| Awendo | Awendo | Kenya | 1 |
| Bomet | Bomet | Kenya | 1 |
| Bondo | Bondo | Kenya | 2 |
| Burnt Forest | Burnt Forest | Kenya | 1 |
| Busia | Busia | Kenya | 2 |
| Eldoret | Eldoret | Kenya | 20 |
| Eldoret | Eldoret | Kenya | 1 |
| Eldoret | Eldoret | Kenya | 3 |
| Eldoret | Eldoret | Kenya | 4 |
| Gatundu | Gatundu | Kenya | 1 |
| Hola | Hola | Kenya | 1 |
| Homa Bay | Homa Bay | Kenya | 5 |
| Homabay County | Homabay County | Kenya | 1 |
| Isibania | Isibania | Kenya | 1 |
| Isiolo | Isiolo | Kenya | 1 |
| Kapsabet | Kapsabet | Kenya | 1 |
| Kericho | Kericho | Kenya | 8 |
| Kericho | Kericho | Kenya | 1 |
| Kericho | Kericho | Kenya | 2 |
| Kiambu | Kiambu | Kenya | 1 |
| Kijabe | Kijabe | Kenya | 1 |
| Kikuyu | Kikuyu | Kenya | 1 |
157 results · Page 1 of 7
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessing the Effects of a Multisectoral Agricultural Intervention on the Reproductive and Sexual Health of Adolescent Girls and Young Women | Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, infectious disease, sexually transmitted disease | Recruiting | Not applicable | 2026-10-08 | NCT06953310 | |
| Integrated Mental Health Care for Pregnant Women With HIV in Kenya: The Tunawiri Study | AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, psychiatric disorder, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2026-10-08 | NCT06117163 | |
| Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Recruiting | Phase 2 | 2026-10-05 | NCT06192160 | |
| DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053) | HIV-1 Infection | Active, not recruiting | Phase 3 | 2026-10-05 | NCT05705349 | |
| RVF and Other Emerging Infectious Diseases in East and Central Africa | Bunyaviridae infectious disease, Communicable Diseases, Emerging, Digestive System Diseases, Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Rift valley fever, arbovirus infection, hepatitis, hepatitis, non-human animal, hepatitis, viral, animal, infectious disease, liver disorder, non-human animal disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Not stated | 2026-10-05 | NCT05139524 | |
| A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-10-02 | NCT05296798 | |
| Lead Exposure Intervention Program | High Blood Lead Level; Lead Exposure | Not yet recruiting | Not applicable | 2026-09-30 | NCT07401251 | |
| A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Sickle Cell Trait, Vaso-Occlusive Crises, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Recruiting | Phase 3 | 2026-09-28 | NCT06439082 | |
| Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya | AIDS, Blood-Borne Infections, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, cervix disorder, dysplasia of cervix, female reproductive system disorder, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, neoplasm, precancerous condition, sexually transmitted disease, uterine carcinosarcoma, uterine disorder, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Not applicable | 2026-09-24 | NCT07468695 | |
| Bioneer Q-RFIA Clinical Evaluation | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Recruiting | Not stated | 2026-09-23 | NCT05117788 | |
| Precision Imaging to Evaluate Kaposi Sarcoma | DNA Virus Infections, Herpesviridae infectious disease, Infections, Kaposi's sarcoma, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma, vascular cancer, viral infectious disease | Recruiting | Not applicable | 2026-09-21 | NCT06898203 | |
| A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-09-21 | NCT05894239 | |
| A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) | Relapsing Multiple Sclerosis | Active, not recruiting | Phase 3 | 2026-09-21 | NCT04586010 | |
| A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010) | AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 3 | 2026-09-18 | NCT07071623 | |
| A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) | AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 3 | 2026-09-18 | NCT07044297 | |
| A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease, thalassemia | Recruiting | Phase 3 | 2026-09-18 | NCT06609226 | |
| A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Recruiting | Phase 2 | 2026-09-18 | NCT06198712 | |
| Evaluation of a Mobile Health Intervention to Improve Sexual and Reproductive Health Outcomes Among Kenyan Adolescents Living in Urban Informal Settlements | Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, infectious disease, sexually transmitted disease | Active, not recruiting | Not applicable | 2026-09-17 | NCT07587281 | |
| Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Not applicable | 2026-09-17 | NCT06708351 | |
| A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Recruiting | Phase 3 | 2026-09-17 | NCT06612268 | |
| Low INR to Minimize Bleeding With Mechanical Valves Trial | Embolism and Thrombosis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, cardiovascular disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-17 | NCT03636295 | |
| Pilot of an AI-Enabled Autism Caregiver Support Tool in Indiana and Kenya | autism spectrum disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder | Not yet recruiting | Not applicable | 2026-09-16 | NCT07821619 | |
| Building Respiratory Support in East Africa Through High Flow Versus Standard Flow Oxygen Evaluation | Acute Hypoxemia | Active, not recruiting | Not applicable | 2026-09-15 | NCT05754034 | |
| A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) | Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | Active, not recruiting | Phase 3 | 2026-09-14 | NCT06065748 | |
| Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2) | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 2 | 2026-09-10 | NCT07811908 |